Congratulations to Dr Xianghui Du, Dr Joyce Wang and colleagues at Zhejiang Cancer Hospital, Hangzhou, who randomised their 1st 4 patients to SUPREMO in September, following activation of the site on 27th Aug 09. Of the 31 international patients randomised to SUPREMO, 14 have been recruited from China, 6 from Australia, 6 from Ireland, 3 from Japan and 2 from Singapore.
The increased rate of recruitment to SUPREMO has been sustained over the summer and 31 patients were randomised to the trial during September. The SUPREMO team would like to congratulate the research teams at the following sites for their valued contributions during September:

• Dr Vivek Misra, Ms Wendy Cook and Ms Joanna Johnson at Royal Oldham Hospital who randomised their 1st patient to the trial in September
• Dr Geraldine Skailes, Ms Clare Tibke and Ms Mary Robinson at Royal Lancaster Infirmary who randomised their 1st patient to the trial in September.
• Dr Goudarz Mazdai and Ms Judith Moore for completing all the necessary approvals to open SUPREMO to recruitment at South Tyneside General Hospital.
• Dr Dayle Hacking, Dr Wojciech Sadiadek, Ms Catriona McDonald, Ms Eimer O'Neill, Ms Vicki Hovenden. Ms Flordeliza Calcasan and Ms Karen Fagen for completing all the necessary approvals to open SUPREMO to recruitment at UMPC Whitfield Cancer Centre, Waterford
• Prof David Joseph, Clin Prof Nigel Spry, Dr Mandy Taylor, Dr Christobel Saunders, Ms Rosalind Stott, Ms Alberta Abreu, Ms Jeannie Hue and Robin Kane for completing all the necessary approvals to open SUPREMO to recruitment at Sir Charles Gairdner Hospital, Perth.

Thanks are also due to the research teams at the following centres who have randomised patients to SUPREMO in September [patients in Sept/ total patients recruited to date by site]:
Dr Elzbieta Senkus-Konefka, Medical University of Gdansk (2/9)
Dr Abbas Chittalia, Stepping Hill Hospital, Stockport (2/8)
Dr Daniela Lee, Newcastle General Hospital (2/7)
Dr Matthew Hatton, Weston Park Hospital, Sheffield (1/21)
Dr Nicola Russell, Antoni Van Leeuwenhoekziekenhuis, Amsterdam (1/20)
Dr Lisa Barraclough, Macclesfield District General Hospital (1/14)
Dr Nihal Shah, Mount Vernon Cancer Centre (1/14)
Dr Adrian Harnett, Norfolk & Norwich University Hospital (1/13)
Dr Richard Welch, Royal Bolton Hospital (1/11)
Dr Martin Rolles, Singleton Hospital, Swansea (1/11)
Dr Pamela Woodings, Derbyshire Royal Infirmary (1/7)
Dr John Dewar, Ninewells Hospital, Dundee (1/7)
Dr Anne Robinson, Southend Hospital (1/7)
Dr Joe Martin, University Hospital, Galway (1/6)
Dr Jonathan Hicks, Wishaw General Hospital (1/5)
Dr Mark Churn, Kidderminster General Hospital (1/5)
Dr Chris Cottrill, Barts & The London NHS Trust (1/5)
Dr Martin Hogg, Royal Preston Hospital (1/3)
Dr Adel Courdi, Antoine Lacassagne, France (1/3)
Dr Katsumasa Kuroi, Komagome Hospital, Tokyo (1/3)
Dr Feng-yan Li, Sun Yat-sen University Cancer Centre, China (1/3)
Dr Geertjen van Tienhoven, Academisch Medisch Centrum, Amsterdam (1/2)

550 patients have now been recruited to SUPREMO and we would like to thank you for your continued support of the trial.
With kind regards,
Professor Ian Kunkler
Chief Investigator, MRC/EORTC SUPREMO trial